The synuclein family has long been associated with Parkinson's disease and dementia. Although the self-assembly of ␣-synuclein (␣S) into oligomers and amyloid fibrils is well established, the aggregation propensity of other members of the family and their role in disease is still under debate. Moriarty et al. now suggest that the pH switching that occurs between different cellular environments could control ␤-synuclein (␤S) aggregation via altering its charge distribution, thus opening new possible roles for ␤S in Parkinson's and other neurodegenerative diseases.
␤S was anticipated to lack aggregation propensity. Indeed, ␤S was suggested to inhibit ␣S fibrillation and ameliorate disease (4) . However, in other studies, fibrillation of ␤S has been observed and associated with neurodegeneration (5) , and the presence of external substances such as environmental pollutants enhanced ␤S aggregation (6) .
Given that synucleins are found in several different cellular compartments where the pH varies and that previous studies showed impacts of changing pH on amyloid protein fibrillation rates, Moriarty et al. (2) tested this effect and found that ␤S formed fibrils at a slightly acidic pH found along the endosomal pathway (pH 5.8), but not at pH 7.3. The importance of the different domains of ␤S in fibrillation and pH regulation was investigated by constructing eight chimeras, in which the three domains of ␣S and ␤S were swapped. Fibril formation and kinetics were monitored via atomic-force microscopy (AFM) and binding to the amyloid-indicator dye thioflavin T. The chimeras revealed that all three domains regulate fibrillation of ␤S, although in markedly different ways. An inhibitory effect on fibrillation was attributed to the C-terminal domain, which has the lowest sequence identity (ϳ30%) to ␣S. In contrast, the N-terminal domain appeared critical for ␤S fibrillation. Swapping ␤S and ␣S N-terminal domains (90% sequence identity) induced a relatively small effect on fibrillation rate in most chimeras. However, the chimera containing the N-terminal domain of ␣S with the NAC and C-terminal domains of ␤S showed no fibrillation, even at acidic pH, which may indicate interdependent relations between the different domains. The role of the N-terminal domain in regulating fibrillation was also supported by computational modeling in which ␤S was threaded onto the solid-state NMR-based structure of ␣S (7) and simulated using Rosetta Symmetry (8) . The simulations suggested that the N-terminal domain is imperative for the formation and stability of a Greek-key-like architecture observed for ␣S (2) . NMR analysis of the ␤S monomer also suggested interactions between the N-terminal and NAC domains. Moreover, a glutamate to alanine alteration at position 31 (E31A) in the N-terminal domain delayed fibrillation of ␤S (Fig. 1) , supporting the involvement of this domain in aggregation (2) .
What is the role of the NAC domain? The chimeras constructed by Moriarty et al. reinforced the critical role of this domain in ␣S fibrillation regardless of the tested pH and the identity of the other domains. Moreover, the chimeras containing the NAC domain of ␣S exhibited faster fibrillation than all their equivalent chimeras containing the NAC domain of ␤S. Importantly, the chimeras that included the NAC domain of ␤S fibrillated only at acidic pH, suggesting that a pH switch is likely dependent on this domain. Accordingly, mutation of the first
The author declares that she has no conflicts of interest with the contents of this article. residue at the NAC domain, which is occupied by a glutamate residue in both ␣S and ␤S, into an alanine (E61A) abolished the pH switch and resulted in rapid and robust fibrillation of ␤S at both neutral and acidic pH. Because ␤S lacks the critical hydrophobic stretch that is present in the NAC domain of ␣S (3), fibrillation might be nucleated via alternative core segments, either in the NAC or N-terminal domains. Interestingly, an amyloid-like structure was determined for a 10-residue segment from the N-terminal domain of ␣S that included the A53T mutation observed in families with inherited forms of Parkinson's disease (9) . The equivalent segment in ␤S, 47 GVVQGVASVA 56 , is predicted to be highly amyloidogenic according to the 3D-profile method ( Fig. 1) (10) , with a higher amyloid-forming propensity score than that of the equivalent ␣S wild-type segment. It puts forward the possible involvement of this region in nucleating fibrillation of ␤S.
The results of Moriarty et al. suggest a possible biological and pathophysiological role of ␤S fibrils in specific microenvironments and inside organelles. The authors postulated that the pH switch stems from rearrangement of charge distribution involving altered protonation of side chains that regulate fibrillation propensities via "polar zippers." It is striking that residue Glu-61, which appears to be critical for controlling the pH switch, is conserved in ␣S, which already fibrillates at both pH values. This highlights the complex regulation of these two synuclein homologs and supports the possibility of different nucleation regions. Regardless of whether the Greek-key-like architecture of ␣S is preserved in ␤S, it is very likely that the regions forming ␤-sheet interactions differ between ␣S and ␤S. Thus, elucidating the high-resolution structure of the ␤S fibril core will provide important information into how this polymorphism may occur. What about ␥-synuclein (␥S), another member of the family? Fibrillation should be expected because it shows high sequence conservation between the N-terminal and NAC domains with ␣S (67% sequence identity) but has a significantly shorter and variable C-terminal domain. Yet, previous results show lack of fibrillation (4), which might be related to the microenvironment tested, as shown for ␤S, or to a critical inhibitory role of the short C-terminal domain. Overall, this manuscript further demonstrates the complexity of the amyloid fold and its vast polymorphism. It will be intriguing to figure out how this complex regulation of fibrillation evolved in a specific protein family and whether this was a dedicated process or a mishap leading to human diseases. EDITORS' PICK HIGHLIGHT: Getting in charge of ␤-synuclein
